Items where authors include "Griffiths, R"

Export as [feed] Atom [feed] RSS
Number of items: 6.

Article

Griffiths, R, Page, L, McDougall, T et al. (3 more authors) (2023) Staff responses to self-harm by children and young people in mental health inpatient settings: Experiences and views of children and young people, parents, and staff. International Journal of Mental Health Nursing. ISSN 1445-8330

Brown, JE, Royle, K-L orcid.org/0000-0003-0225-1199, Gregory, W et al. (96 more authors) (2023) Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. The Lancet Oncology, 24 (3). pp. 213-227. ISSN 1470-2045

Griffiths, R, Dawber, A, McDougall, T et al. (2 more authors) (2022) Non‐restrictive interventions to reduce self‐harm amongst children in mental health inpatient settings: Systematic review and narrative synthesis. International Journal of Mental Health Nursing, 31 (1). pp. 35-50. ISSN 1445-8330

Baird, R, Banks, I, Cameron, D et al. (53 more authors) (2016) An Association of Cancer Physicians’ strategy for improving services and outcomes for cancer patients. Ecancermedicalscience, 10. 608.

Conference or Workshop Item

Vasudev, NS orcid.org/0000-0001-8470-7481, Ainsworth, G, Brown, S orcid.org/0000-0002-7975-7537 et al. (17 more authors) (2021) LBA29 Nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced renal cell carcinoma: A randomized phase II trial (PRISM). In: ESMO Congress 2021, 16-21 Sep 2021, Virtual.

Proceedings Paper

Brown, JE, Royle, K-L orcid.org/0000-0003-0225-1199, Ralph, C et al. (17 more authors) (2021) STAR: A randomised multi-stage phase II/III trial of standard first-line therapy (sunitinib or pazopanib) comparing temporary cessation with allowing continuation, in the treatment of locally advanced and/or metastatic renal Cancer (RCC). In: Annals of Oncology. ESMO Congress 2021, 16-21 Sep 2021, Paris, France. Elsevier , S1303-S1304.

This list was generated on Sat Apr 20 18:33:56 2024 BST.